Stocks
GlaxoSmithKline (GSK) EV US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EV, £ | ? | 97 482 499 100 | 13 110 000 000 | 16 363 332 800 | 82 214 070 000 | 113 619 361 000 | 122 491 453 000 | ||
| Changes by years, y/y, % | -4% | -87% | +25% | +402% | +38% | +2.3% | |||
GlaxoSmithKline. EV, £
GlaxoSmithKline. EV, changes, %
GlaxoSmithKline (GSK) EV US GAAP (quarter values) |
||||||||
| FY2025Q3 | FY2025Q4 | FY2025Q4 | FY2026Q1 | FY2026Q2 | LTM ? | |||
| EV, £ | ? | 106 498 955 000 | 112 834 721 000 | 63 561 781 000 | 131 603 548 000 | 120 247 607 000 | 122 491 453 000 | |
| Changes by years, y/y, % | +11% | +37% | -23% | +35% | +24% | |||
| Changes by quarters, q/q, % | +10% | +6% | -44% | +107% | -9% | |||
